IL6 and neoplasm: It also favorably altered immune dynamics within the tumor microenvironment by decreasing levels of IL-6, IL-10, and TGF-β, as well as polymorphonuclear MDSCs (PMN-MDSCs), while increasing IFN-γ and NK cells (141).